Once-daily dosing with the OROS formulation of methylphenidate has minimal impact on tics in children with ADHD

被引：0
|
作者：
Palumbo, DR
Starr, HL
机构：
来源：
ANNALS OF NEUROLOGY | 2003年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [41] Effectiveness and safety of a long-acting, once-daily, two-phase release formulation of methylphenidate (Ritalin (R) LA) in school children under daily practice conditions
    Haertling, Fabian
    Mueller, Beate
    Bilke-Hentsch, Oliver
    ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS, 2015, 7 (02) : 157 - 164
  • [42] Model-Informed Once-Daily Dosing Strategy for Bedaquiline and Delamanid in Children, Adolescents and Adults with Tuberculosis
    Lin, Yu-Jou
    van Der Laan, Louvina E.
    Karlsson, Mats O.
    Garcia-Prats, Anthony J.
    Hesseling, Anneke C.
    Svensson, Elin M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024,
  • [43] Galantamine prolonged-release formulation permits once-daily dosing in patients with mild to moderate Alzheimer's disease
    Brodaty, H
    Schwalen, S
    Gold, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S333 - S334
  • [44] Complementary pharmacokinetic measures to further define the profile of once-daily OROS hydromorphone ER during single-dose and steady-state dosing
    Devarakonda, Krishna
    Vandenbossche, Joris
    Richarz, Ute
    SPRINGERPLUS, 2013, 2 : 1 - 9
  • [45] Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism
    François Laliberté
    Brahim K. Bookhart
    Winnie W. Nelson
    Patrick Lefebvre
    Jeff R. Schein
    Jonathan Rondeau-Leclaire
    Mei Sheng Duh
    The Patient - Patient-Centered Outcomes Research, 2013, 6 : 213 - 224
  • [46] Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism
    Laliberte, Francois
    Bookhart, Brahim K.
    Nelson, Winnie W.
    Lefebvre, Patrick
    Schein, Jeff R.
    Rondeau-Leclaire, Jonathan
    Duh, Mei Sheng
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2013, 6 (03): : 213 - 224
  • [47] An observational study of once-daily modified-release methylphenidate in ADHD: The effect of previous treatment on ADHD symptoms, other externalising symptoms and quality-of-life outcomes
    Döpfner M.
    Breuer D.
    Walter D.
    Rothenberger A.
    European Child & Adolescent Psychiatry, 2011, 20 (Suppl 2) : S277 - S288
  • [48] Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD
    McGough, JJ
    Biederman, J
    Wigal, SB
    Lopez, FA
    McCracken, JT
    Spencer, T
    Zhang, YX
    Tulloch, SJ
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2005, 44 (06): : 530 - 538
  • [49] Dose conversion and titration with a novel, once-daily, OROS® osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain
    Palangio, M
    Northfelt, DW
    Portenoy, RK
    Brookoff, D
    Doyle, RT
    Dornseif, BE
    Damask, MC
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 23 (05) : 355 - 368
  • [50] Efficacy of once-daily cyclosporine in Japanese children with steroid-dependent minimal change nephrotic syndrome
    Fujinaga, Shuichiro
    Nishino, Tomohiko
    Urushihara, Yasuko
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (02) : 213 - 214
12345